Altered frequency of FOXP3+ regulatory T cells is associated with development of inhibitors in patients with severe hemophilia A
Authors:
- 24 July 2023
- journal article
- research article
- Published by Wiley in International Journal of Laboratory Hematology
- Vol. 45 (6) , 953-960
Abstract
Introduction: The development of anti-factor VIII (FVIII) antibodies or "inhibitors" is a major complication following FVIII replacement therapy in patients with severe hemophilia A (HA), rendering the treatment inefficient. Data on the role of regulatory T cells (Tregs) in inhibitor formation in these patients are rare. Herein, we aimed to investigate whether a difference in the FOXP3+ Tregs is linked to the formation of the inhibitors in severe HA patients. Methods: In this cross-sectional study, 32 patients with severe HA (8 patients with inhibitors and 24 without inhibitors) and 24 healthy controls were enrolled. The frequency of FOXP3+ Tregs was determined using multicolor flow cytometry method. Results: Our results showed that the median level of CD4(+)CD25(+)FOXP3(+) Tregs did not significantly differ between HA patients and healthy controls and between HA patients with and without inhibitors (P > 0.05). However, patients with inhibitors had significantly lower amounts of CD4(+)CD25(similar to)FOXP3(+) Tregs compared to those without inhibitors as well as healthy controls (*P = 0.012 and *P = 0.004, respectively). The frequency of CD4(+)CD25(+) T cells was significantly higher in HA patients who developed inhibitors compared to the inhibitor-negative ones whereas they were lower in inhibitor-negative patients compared to the healthy controls (*P = 0.013 and *P = *0.029, respectively). The percentages of CD4+CD25+ T cells were positively correlated with the levels of inhibitors in HA patients (r = 0.45, *P = 0.021). Conclusion: Our data demonstrated for the first time that the CD4(+)CD25(similar to)FOXP3(+) Tregs might be implicated in the prevention of inhibitor formation in severe HA patients.Keywords
This publication has 28 references indexed in Scilit:
- The immunoregulatory role of CD4+FoxP3+CD25−regulatory T cells in lungs of mice infected withBordetella pertussisFEMS Immunology & Medical Microbiology, 2012
- In Vivo Expansion of Regulatory T cells With IL-2/IL-2 mAb Complexes Prevents Anti-factor VIII Immune Responses in Hemophilia A Mice Treated With Factor VIII Plasmid-mediated Gene TherapyMolecular Therapy, 2011
- Immunomodulation for inhibitors in hemophilia A: the important role of Treg cellsExpert Review of Hematology, 2010
- FOXP3+ regulatory T cells in the human immune systemNature Reviews Immunology, 2010
- Identity of mysterious CD4+CD25-Foxp3+ cells in SLEArthritis Research & Therapy, 2010
- CD4+FOXP3+ regulatory T cells confer long-term regulation of factor VIII–specific immune responses in plasmid-mediated gene therapy–treated hemophilia miceBlood, 2009
- Are CD4+CD25-Foxp3+cells in untreated new-onset lupus patients regulatory T cells?Arthritis Research & Therapy, 2009
- Genetic risk factors for inhibitors to factors VIII and IXHaemophilia, 2006
- Haemophilia A: from mutation analysis to new therapiesNature Reviews Genetics, 2005
- Incidence of development of factor VIII and factor IX inhibitors in haemophiliacsThe Lancet, 1992